Loading clinical trials...

GrafixPRIME® for the Treatment of Chronic Diabetic Foot Ulcers | Clinical Trials | Clareo Health

COMPLETEDPhase 4NCT02675855

GrafixPRIME® for the Treatment of Chronic Diabetic Foot Ulcers

The objective of the study is to compare the efficacy of weekly GrafixPRIME® administration to an Active Comparator in patients with chronic DFUs in a randomized, single-blind study.

Lead sponsor: Osiris Therapeutics•3 U.S. locations•View source on ClinicalTrials.gov

Clareo plain-language summary

What this study is about

Generating AI summary...

Clareo turns complex medical information into clear understanding you can use.

Bring this clarity to your next appointment.

Keep all your medical notes and next steps in one place.

Related studies

RECRUITINGNA

Evaluating a Lifestyle Intervention to Prevent Recurrence of Diabetic Foot Ulcers

NCT06487780 · Diabetic Foot, Diabetic Foot Ulcer, and more

Active Not RecruitingPhase 1

Study to Assess the Safety of DERMASEAL for Diabetic Foot Ulcers

NCT05586542 · Foot Ulcer, Diabetic

COMPLETEDNA

Pressure Alternating Shoes

NCT06026813 · Foot Ulcer, Diabetic

COMPLETEDNA

Time to Heal (Wound, Healing, Dialogue, Nutrition)

NCT06255288 · Leg Ulcer, Venous Leg Ulcer, and more

TERMINATEDNA

Prevention of Primary Foot Ulcers in High-risk Diabetes Patients

NCT03958539 · Diabetes Mellitus, Foot Ulcer, Diabetic, and more

View all related studies →

Data from ClinicalTrials.govLast updated on ClinicalTrials.gov: July 17, 2017Terms

Trial snapshot

StatusCOMPLETED

PhasePHASE4

Enrollment75

Start dateJan 2016

Last updatedJul 17, 2017

Condition

Foot Ulcer, Diabetic

Locations shown

Arizona City, Arizona

California City, California

New Mexico, New Mexico

For caregivers

Use Clareo to keep notes, questions, trial details, and next steps organized before and after appointments.

Data Source & Attribution

This clinical trial information is sourced from ClinicalTrials.gov, a service of the U.S. National Institutes of Health.

ClinicalTrials.gov last update: July 17, 2017Data synced to Clareo: May 10, 2026

Modifications: This data has been reformatted for display purposes. Eligibility criteria have been parsed into inclusion/exclusion sections. Location data has been geocoded to enable distance-based search. For the authoritative and most current information, please visit ClinicalTrials.gov.

Neither the United States Government nor Clareo Health make any warranties regarding the data. Check ClinicalTrials.gov frequently for updates.

View ClinicalTrials.gov Terms and Conditions